Terms: = Lymphoma AND TAL2, Q16559, 6887
17 results:
1. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract] [Full Text] [Related]
2. Primary central nervous system T-cell lymphoma: An analysis from the surveillance, epidemiology, and end results program.
Long H; Li S; Zhang Y; Li R; Fong T; Yang C; Wang H; Xu N; Xu Y; Wang K; Yang K; Qi S; Wang J
J Clin Neurosci; 2020 Sep; 79():74-79. PubMed ID: 33070923
[TBL] [Abstract] [Full Text] [Related]
3. Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.
Matsuda S; Suzuki R; Takahashi T; Suehiro Y; Tomita N; Izutsu K; Fukuhara N; Imaizumi Y; Shimada K; Nakazato T; Yoshida I; Miyazaki K; Yamaguchi M; Suzumiya J
Int J Hematol; 2020 Dec; 112(6):807-816. PubMed ID: 32880824
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of salvage therapy with MTX-HOPE for elderly patients with heavily pretreated non-Hodgkin's lymphoma.
Fukunaga A; Okamoto Y; Shibata S; Inano S; Takiuchi Y; Yamamoto K; Tabata S; Kitano T
J Clin Exp Hematop; 2020 Jun; 60(2):37-40. PubMed ID: 32404568
[TBL] [Abstract] [Full Text] [Related]
5. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
Steiner R; Kridel R; Giostra E; McKee T; Achermann R; Mueller N; Manuel O; Dickenmann M; Schuurmans MM; de Leval L; Fehr T; Tinguely M; Binet I; Cogliatti S; Haralamvieva E; Koller M; The Swiss Transplant Cohort Study Stcs ; Dietrich PY
Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251
[TBL] [Abstract] [Full Text] [Related]
6. Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables.
Walsh A; Chewning J; Li X; Dai C; Whelan K; Madan-Swain A; Waterbor J; Baskin ML; Goldman FD
Pediatr Blood Cancer; 2017 Feb; 64(2):267-274. PubMed ID: 27650428
[TBL] [Abstract] [Full Text] [Related]
7. Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?
Goldshtein A; Berger M
Crit Rev Oncog; 2014; 19(5):399-404. PubMed ID: 25404153
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract] [Full Text] [Related]
9. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
Marculescu R; Le T; Simon P; Jaeger U; Nadel B
J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
[TBL] [Abstract] [Full Text] [Related]
10. The leukemic oncogene tal-2 is expressed in the developing mouse brain.
Mori S; Sugawara S; Kikuchi T; Tanji M; Narumi O; Stoykova A; Nishikawa SI; Yokota Y
Brain Res Mol Brain Res; 1999 Feb; 64(2):199-210. PubMed ID: 9931488
[TBL] [Abstract] [Full Text] [Related]
11. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.
Wadman I; Li J; Bash RO; Forster A; Osada H; Rabbitts TH; Baer R
EMBO J; 1994 Oct; 13(20):4831-9. PubMed ID: 7957052
[TBL] [Abstract] [Full Text] [Related]
12. [Molecular study of hematological diseases].
Hirosawa S
Rinsho Byori; 1994 Jun; 42(6):622-7. PubMed ID: 7914242
[TBL] [Abstract] [Full Text] [Related]
13. Products of the tal2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
Xia Y; Hwang LY; Cobb MH; Baer R
Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
[TBL] [Abstract] [Full Text] [Related]
14. TAL1, tal2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract] [Full Text] [Related]
15. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract] [Full Text] [Related]
16. SCL and related hemopoietic helix-loop-helix transcription factors.
Green AR; Begley CG
Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
[TBL] [Abstract] [Full Text] [Related]
17. tal2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.
Xia Y; Brown L; Yang CY; Tsan JT; Siciliano MJ; Espinosa R; Le Beau MM; Baer RJ
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11416-20. PubMed ID: 1763056
[TBL] [Abstract] [Full Text] [Related]
